TRANSCENTA HOLDING LIMITED

Press Releases Transcenta Holding Limited

Equities

6628

KYG9005B1041

Market Closed - Hong Kong S.E. Other stock markets 09:08:22 10/05/2024 BST			5-day change	1st Jan Change
1.89 ^HKD	0.00%		+4.42%	-47.35%

04-30	Transcenta Holding Limited Announces Board and Nomination Changes	CI
04-09	Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference.	02/06/23	PR
Transcenta's Osemitamab Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer	30/03/23	AQ
Transcenta to Present Two Preclinical Studies at AACR 2023	23/03/23	AQ
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors	23/03/23	AQ
Transcenta Holding Limited (6628.HK) to Hold 2022 Annual Results Release Conference Call	20/03/23	PR
Transcenta Holding Limited - Results of CLDN18.2-targeting Immuno-PET Probe for Non-invasive Imaging in Gastrointestinal Tumors Published	06/03/23	AQ
Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update	09/11/22	PR
Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting	14/10/22	PR
Claudin18.2, a shining star in gastric cancer, Transcenta's TST001 stands at the global forefront	28/09/22	AQ
Transcenta Holding Product pipeline progressing well	01/09/22	AQ
Transcenta Holding (06628): Product pipeline progressing well with significant competitive differentiation	01/09/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer